If you have any question, please feel free to email us. We will touch with you as soon as possible.
For R&D purposes only. Lixianahas the 3 indications of prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF), treatment and recurrence prevention of venous thromboembolism (VTE) [deep vein thrombosis (DVT) and pulmonary thromboembolism (PE)], and prevention of VTE after major orthopedic surgery, and is currently widely used in the prevention and treatment of thromboembolism.
* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.
Generic name | Edoxaban Tosilate Orally Disintegrating Tablets |
Trade name | Lixiana |
Specification | 30mg, 60mg |
Main ingredients | Edoxaban Tosilate |
Dosage Form | Orally Disintegrating Tablet |
MA Holder | 第一三共株式会社 |
Category | Reference Listed Drugs (RLDs) |
Indications:
Lixianahas the 3 indications of prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF), treatment and recurrence prevention of venous thromboembolism (VTE) [deep vein thrombosis (DVT) and pulmonary thromboembolism (PE)], and prevention of VTE after major orthopedic surgery, and is currently widely used in the prevention and treatment of thromboembolism.
For more details, pls contact Janney:
Email: tosun-global@upharm.cn
Wechat/Whatsapp:(+86)18922120575
Hot Tags: edoxaban tosilate orally disintegrating tablets reference listed drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Adefovir Dipivoxil Tablets, Olanzapine Tablets, Acarbose Tablets, Esomeprazole Magnesium Enteric Coated Capsules, Agomelatine Tablets, Alfacalcidol Soft Capsules
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China